Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 16.9.2024B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))16.9.2024O
 16.9.2024STADA Arzneimittel AG (STD)9662DDeferasirox STADA 180 mg filmom obalené tablety (tbl flm 30x1x180 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.))5.9.2024U
 16.9.2024STADA Arzneimittel AG (STD)9668DDeferasirox STADA 360 mg filmom obalené tablety (tbl flm 30x1x360 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.))5.9.2024U
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2201CCalcium folinate Sandoz 10 mg/ml (sol ijf 1x10 ml/100 mg (liek.inj.skl.jantárová))12.9.2024Z
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)72973Amoksiklav 600 mg (plo ijf 5x600 mg (liek.inj.skl.))1.9.2024Z
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)82673Methotrexat Sandoz 20 mg/ ml (sol iru 1x1 ml/20 mg (striek.skl.napl.))12.9.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2203CCalcium folinate Sandoz 10 mg/ml (sol ijf 1x35 ml/350 mg (liek.inj.skl.jantárová))12.9.2024Z
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)96249Sumatriptan Sandoz 100 mg tablety (tbl 4x100 mg (blis.Al/Al))1.9.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7569BEplerenon Sandoz 25 mg filmom obalené tablety (tbl flm 90x25 mg (blis.PVC/Al))1.8.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7564BEplerenon Sandoz 25 mg filmom obalené tablety (tbl flm 30x25 mg (blis.PVC/Al))1.9.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)02131Gemliquid 40 mg/ml (con inf 1x25 ml/1000 mg (liek.inj.skl. + ochr.obal))12.9.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)6929BImatinib Sandoz 400 mg (tbl flm 30x400 mg (blis.PVC/PE/PVDC/Al))1.8.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)6926BImatinib Sandoz 100 mg (tbl flm 60x100 mg (blis.PVC/PE/PVDC/Al))1.8.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)1485AKyselina zoledrónová Sandoz 4 mg/5 ml infúzny koncentrát (con inf 1x5 ml/4 mg (liek.inj.plast.))1.8.2024O
 13.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)32939Paclitaxel Sandoz 6 mg/ ml (con inf 1x16,7 ml/100 mg (liek.inj.skl.))1.8.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)